Adma Biologics reported $41.93M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Adma Biologics USD 41.93M 4.34M Jun/2025
Alnylam Pharmaceuticals USD 4.89M 13.19M Jun/2025
Dynavax Technologies USD 10.86M 34.49M Jun/2025
Takeda JPY 257.79B 387.52B Jun/2025